NCT02576353View on ClinicalTrials.gov

Fentanyl Sublingual Spray and Fentanyl Citrate Intravenous (IV) in Opioid Naive Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Pharmacokinetics and Pharmacodynamics
Interventions
DRUG

Fentanyl

Fentanyl Sublingual Spray (FSS)

DRUG

Fentanyl Citrate

Fentanyl Citrate IV (FCIV)

Trial Locations (1)

91105

Lotus Clinical Research, Pasadena

Sponsors
All Listed Sponsors
lead

INSYS Therapeutics Inc

INDUSTRY